drugset / Trial / NCT07842640
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight
RandomizedSequentialTriple-blindTreatment
Summary
This randomized, double-blind, placebo-controlled single ascending dose (SAD)/ multiple ascending dose (MAD) study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ASC35 injection
Timeline
- Start
- 2026-08-27
- Primary completion
- 2027-06
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASC35 | Unknown | — | Subcutaneous |
| Comparator | Tirzepatide | Peptide | — | Subcutaneous |
Indications
No indication recorded.